Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms

ISSN： 0885-7490

Source： Metabolic Brain Disease, Vol.27, Iss.2, 2012-06, pp. : 121-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IgE-Mediated Hypersensitivity and Desensitisation with Recombinant Enzymes in Pompe Disease and Type I and Type VI Mucopolysaccharidosis

International Archives of Allergy and Immunology, Vol. 169, Iss. 3, 2016-05 ,pp. : 198-202

Karger

Access to resources Recommend Favorite

Dysregulation of gene expression in neurodegeneration

NEUROPATHOLOGY & APPLIED NEUROBIOLOGY, Vol. 41, Iss. 2, 2015-02 ,pp. : 109-134

John Wiley & Sons Inc

Access to resources Recommend Favorite

Urethral Instability: Current Pathophysiological Concept

Urologia Internationalis, Vol. 83, Iss. 2, 2009-09 ,pp. : 125-133

Karger

Access to resources Recommend Favorite

Psychological Stress and Puerperal Mastitis - Possible Pathophysiological Mechanisms

Current Women's Health Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 123-127

Bentham Science Publishers

Access to resources Recommend Favorite

Galsulfase: enzyme-replacement therapy for mucopolysaccharidosis Type VI (Maroteaux––Lamy syndrome)

By Beck Michael

Therapy, Vol. 3, Iss. 1, 2006-01 ,pp. : 9-17

Future Medicine

Access to resources Recommend Favorite